Carbylan Therapeutics Announces Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Grand Canyon Education places CFO on leave amid stock trade probe
- Funds sell $44bn in semiconductors on AI concerns
Carbylan Therapeutics (CBYL) Tops Q3 EPS by 7c
November 11, 2015 7:32 AM ESTCarbylan Therapeutics (NASDAQ: CBYL) reported Q3 EPS of ($0.19), $0.07 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Carbylan Therapeutics (CBYL) click here.
... More